Form 4: CRL Executive Victoria Creamer Reports Stock Disposition
Statement of Changes in Beneficial Ownership
EVP & Chief People Officer Victoria L. Creamer disposed of 346 shares of Charles River Laboratories common stock to cover tax obligations.
Summary
- Victoria L. Creamer, EVP & Chief People Officer at Charles River Laboratories, reported the disposition of 346 shares of common stock.
- The transactions occurred on May 26, 2026 (198 shares at $160.30) and May 27, 2026 (148 shares at $156.73).
- The shares were withheld by the company to satisfy tax withholding obligations related to the vesting of equity awards.
- Following these transactions, the reporting person maintains a beneficial ownership of 25,726 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax compliance.
Positives
- The transaction was a routine administrative action related to tax withholding rather than a discretionary sale of shares.
Negatives
- The reporting person reduced their total beneficial ownership stake in the company.
Risks
- None identified; this is a standard regulatory disclosure for executive compensation tax compliance.
Future Outlook
Not applicable as this is a retrospective disclosure of an executive stock transaction.
Industry Context
StockSavvy.ai notes that routine tax-related share dispositions by executives are standard industry practice and do not typically signal a change in management sentiment regarding company performance.
Comparison to Industry Standards
- The transaction aligns with standard corporate governance practices for equity-based compensation tax withholding at major life sciences firms.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was a non-discretionary tax withholding event.
Next Steps
- None
Key Dates
| Date | Description |
|---|---|
| 05/26/2026 | Transaction date for the disposition of 198 shares. |
| 05/27/2026 | Transaction date for the disposition of 148 shares and filing date. |
Keywords
Charles River Laboratories, CRL, Form 4, Insider Trading, Executive Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.